A True Splenic Cyst Producing Carbohydrate Antigen 19-9 and Cancer Antigens 50 and 125, but Not Interleukin 10Galizia G.a · Lieto E.a · Ferraraccio F.b · Castellano P.a · de Vita F.c · Orditura M.c · Romano C.d · Pignatelli C.a
Divisions of aSurgical Oncology, bPathology, cMedical Oncology and dClinical Immunology, ‘F. Magrassi and A. Lanzara’ Department of Clinical and Experimental Medicine, 2nd University of Naples School of Medicine, Naples, Italy
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
A giant cystic lesion of the left upper abdomen associated with a smaller ovarian cyst in a young female patient is reported. Laboratory data revealed elevated serum levels of carbohydrate antigen 19-9 (CA 19-9), carcino-embryonic antigen (CEA), cancer antigens 50 and 125, and tissue polypeptide antigen. In contrast, the serum levels of interleukin 10, a cytokine involved in modulating immune responses and produced by many cancer histotypes, were normal. Since ovarian cancer or cystic adenocarcinoma of the tail of the pancreas were not ruled out, the patient underwent laparotomy. After splenectomy and ovariectomy, the tumour marker serum levels normalized. Histology and immunohistochemical analysis revealed a true splenic cyst with the inner epithelium strongly positive for CA 19-9 and CEA and high levels of cancer antigens in the fluid. The ovarian lesion was a serous cystadenoma. The inner epithelium showed no immunoreactivity for tumour markers which were not measurable in the fluid. True cysts of the spleen are rare; in a few cases, high serum levels of CA 19-9 and CEA have been reported. In such instances, cyst resection or splenectomy is indicated to rule out malignant lesions and to remove the cancer antigen producing epithelium. The reported case shows that the epithelium lining true splenic cysts may produce, besides CA 19-9 and CEA, other tumour markers, in particular cancer antigens 50 and 125. In addition, normal serum values of interleukin 10 correctly predicted the benign nature of the lesion.
© 2003 S. Karger AG, Basel
- Lopez JB, Royan GP, Lakhwani MN, Mahadaven M, Timor J: CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies. Int J Biol Markers 1999;14:172–177.
- Mann DV, Edwards R, Ho S, Lau WY, Glazer G: Elevated tumour marker CA19-9: Clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000;26:474–479.
- Halm U, Schumann T, Schiefke I, Witzigmann H, Mossner J, Keim V: Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer 2000;82:1013–1016.
- Ito S, Gejyo F: Elevation of serum CA19-9 levels in benign diseases. Intern Med 1999;38:840–841.
Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI: A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: Analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999;94:1941–1946.
- Terada T, Yasoshima M, Yoshimitsu Y, Nakanuma Y: Carbohydrate antigen 19-9 producing giant epithelial cyst of the spleen in a young woman. J Clin Gastroenterol 1994;18:57–61.
- Walz MK, Metz KA, Sastry M, Eigler FW, Leder LD: Benign mesothelial splenic cyst may cause high serum concentration of CA 19-9. Eur J Surg 1994;160:389–391.
- Yoshikane H, Suzuki T, Yoshioka N, Ogawa Y, Hayashi Y, Hamajima E, Yokoi T: Giant splenic cyst with high serum concentration of CA 19-9: Failure of treatment with percutaneous transcatheter drainage and injection of tetracycline. Scand J Gastroenterol 1996;31:524–526.
- Decker D, Bollmann R, Hirner A, Stratmann H: Increased CA-19-9 caused by a splenic cyst: A rare differential diagnosis. Zentralbl Chir 1998;123:855–857.
- Higaki K, Jimi A, Watanabe J, Kusaba A, Kojiro M: Epidermoid cyst of the spleen with CA19-9 or carcinoembryonic antigen productions: Report of three cases. Am J Surg Pathol 1998;22:704–708.
- Sardi A, Ojeda HF, King D Jr: Laparoscopic resection of a benign true cyst of the spleen with the harmonic scalpel producing high levels of CA 19-9 and carcinoembryonic antigen. Am Surg 1998;64:1149–1154.
- Ishibashi R, Sakai T, Yamashita Y, Maekawa T, Hideshima T, Shirakusa T: Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9. Int Surg 1999;84:151–154.
- Sakamoto Y, Yunotani S, Edakuni G, Mori M, Iyama A, Miyazaki K: Laparoscopic splenectomy for a giant splenic epidermoid cyst: Report of a case. Surg Today 1999;29:1268–1272.
van Lacum MW, Hessels RA, Kremer GD, Jaspers CA: A splenic cyst and a high serum CA 19-9: A case report. Eur J Intern Med 2000;11:104–107.
- Soudack M, Ben-Nun A, Toledano C: Elevated carbohydrate antigen 19-9 in patients with true (epithelial) splenic cysts rare or undiscovered? Can J Gastroenterol 2001;15:125–126.
- McLaughlin R, O’Hanlon D, Kerin M, Kenny P, Grimes H, Given HF: Are elevated levels of the tumour marker CA19-9 of any clinical significance? An evaluation. Ir J Med Sci 1999;168:124–126.
- De Vita F, Orditura M, Galizia G, Romano C, Lieto E, Iodice P, Tuccillo C, Catalano G: Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep 2000;7:357–361.
- De Vita F, Orditura M, Galizia G, Romano C, Infusino S, Auriemma A, Lieto E, Catalano G: Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 1999;86:1936–1943.
- Sternberger LA, Sternberger NH: The unlabeled antibody method: Comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem 1986;34:599–605.
- Williams RJ, Glazer G: Splenic cysts: Changes in diagnosis, treatment and aetiological concepts. Ann R Coll Surg Engl 1993;75:87–89.
- de Melo VA, Alves Junior A, Andrade LC, Aragao JF, Rosa JE: Splenic cyst: Review of the literature and report of 2 cases. Rev Hosp Clin Fac Med São Paulo 1995;50:289–293.
- Rohr S, Trombetta V, Maloisel F, Becmeur F, Chenard MP, Meyer C: True benign non-parasitic cysts of the spleen: From diagnosis to treatment. A propos of 5 new cases. J Chir (Paris) 1995;132:467–471.
- Seshadri PA, Poulin EC, Mamazza J, Schlachta CM: Needlescopic decapsulation of a splenic epithelial cyst. Can J Surg 2000;43:303–305.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.